Osteonecrosis of the humeral head in a patient with non-small cell lung cancer receiving Bevacizumab

Journal of Thoracic Oncology

Volumn 6, Issue 11, 2011, Pages 1960-1961

  Koczywas, Marianna ^a   Cristea, Mihaela C ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; CELECOXIB; ERLOTINIB; FLUORODEOXYGLUCOSE; PEMETREXED;

ADULT; AVASCULAR NECROSIS; BRAIN METASTASIS; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMERUS HEAD; LIVER METASTASIS; LUNG ADENOCARCINOMA; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MULTIPLE CYCLE TREATMENT; NOTE; PRIORITY JOURNAL; SHOULDER PAIN; SYMPTOM;

EID: 80054950782     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31822e726f     Document Type: Article

References (2)

1. Mir O, Coriat R, Gregory T, et al. Avascular necrosis of the femoral head: a rare class-effect of anti-VEGF agents. Invest New Drugs 2011; 29:716-718.
2. Assouline-Dayan Y, Chang C, Greenspan A, et al. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 2002;32:94-124. (Pubitemid 35351246)